Turning a corner: Private market posts best month in yearsCore private market metrics suggest positive momentum is brewing and investor sentiment is improving
Turning a corner: Private market posts best month in years
Trading
Data
Solutions
Insights
About
Generate:Biomedicines, founded in 2018, is a biotechnology company and developer of a generative biology platform that seeks to use AI and machine learning to create pharmaceutical therapies on demand. Through its Generate Platform, the company aims to produce therapies for constantly changing clinical targets, with the goal of reducing the time and money required to respond to medical conditions. Generate:Biomedicines is headquartered in Somerville, Massachusetts.
Generate Biomedicines is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Generate Biomedicines pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Generate Biomedicines is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 9/14/2023 | Series C | $273MM raised | $XXX.XX | $XXX.XX |
| 11/18/2021 | Series B | $373.42MM raised | $XXX.XX | $XXX.XX |
| 9/10/2020 | Series A | $40.25MM raised | $XXX.XX | $XXX.XX |
